AAAAAA
Results: 1-25/59
Authors:
Makrigiannakis, A
Zoumakis, E
Kalantaridou, S
Coutifaris, C
Margioris, AN
Coukos, G
Rice, KC
Gravanis, A
Chrousos, GP
Citation: A. Makrigiannakis et al., Corticotropin-releasing hormone promotes blastocyst implantation and earlymaternal tolerance, NAT IMMUNOL, 2(11), 2001, pp. 1018-1024
Authors:
Tian, XR
Hsin, LW
Webster, EL
Contoreggi, C
Chrousos, GP
Gold, PW
Habib, K
Ayala, A
Eckelman, WC
Jacobson, AE
Rice, KC
Citation: Xr. Tian et al., The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type1, BIOORG MED, 11(3), 2001, pp. 331-333
Authors:
Ulrich, T
Dersch, CM
Rothman, RB
Jacobson, AE
Rice, KC
Citation: T. Ulrich et al., Derivatives of 17-(2-methylallyl)-substituted noroxymorphone: Variation ofthe delta address and its effects on affinity and selectivity for the delta opioid receptor, BIOORG MED, 11(21), 2001, pp. 2883-2885
Authors:
Xu, H
Lu, YF
Thomas, JB
Carroll, FI
Rice, KC
Rothman, RB
Citation: H. Xu et al., Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4 piperidinyl) phenylamino]-N,N-diethylbenzamide and related compoundsat the cloned human delta-opioid receptor, SYNAPSE, 40(4), 2001, pp. 269-274
Authors:
Rothman, RB
Baumann, MH
Dersch, CM
Romero, DV
Rice, KC
Carroll, FI
Partilla, JS
Citation: Rb. Rothman et al., Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin, SYNAPSE, 39(1), 2001, pp. 32-41
Authors:
Xu, H
Hashimoto, A
Rice, KC
Jacobson, AE
Thomas, JB
Carroll, FI
Lai, J
Rothman, RB
Citation: H. Xu et al., Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [S-35]GTP-gamma-S functional binding assay, SYNAPSE, 39(1), 2001, pp. 64-69
Authors:
Stafford, D
LeSage, MG
Rice, KC
Glowa, JR
Citation: D. Stafford et al., A comparison of cocaine, GBR 12909, and phentermine self-administration byrhesus monkeys on a progressive-ratio schedule, DRUG AL DEP, 62(1), 2001, pp. 41-47
Authors:
Xu, H
Lu, YF
Rice, KC
Ananthan, S
Rothman, RB
Citation: H. Xu et al., SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [S-35]-GTP-gamma-S binding at cloned opioid receptors, BRAIN RES B, 55(4), 2001, pp. 507-511
Authors:
Gomez-Flores, R
Rice, KC
Zhang, XY
Weber, RJ
Citation: R. Gomez-flores et al., Increased tumor necrosis factor-alpha and nitric oxide production by rat macrophages following in vitro stimulation and intravenous administration ofthe delta-opioid agonist SNC 80, LIFE SCI, 68(24), 2001, pp. 2675-2684
Authors:
Hosohata, Y
Varga, EV
Stropova, D
Li, XP
Knapp, RJ
Hruby, VJ
Rice, KC
Nagase, H
Roeske, WR
Yamamura, HI
Citation: Y. Hosohata et al., Mutation W284L of the human delta opioid receptor reveals agonist specificreceptor conformations for G protein activation, LIFE SCI, 68(19-20), 2001, pp. 2233-2242
Authors:
Brandt, MR
Furness, MS
Rice, KC
Fischer, BD
Negus, SS
Citation: Mr. Brandt et al., Studies of tolerance and dependence with the delta-opioid agonist SNC80 inrhesus monkeys responding under a schedule of food presentation, J PHARM EXP, 299(2), 2001, pp. 629-637
Authors:
Fedorova, I
Hashimoto, A
Fecik, RA
Hedrick, MP
Hanus, LO
Boger, DL
Rice, KC
Basile, AS
Citation: I. Fedorova et al., Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems, J PHARM EXP, 299(1), 2001, pp. 332-342
Authors:
Brandt, MR
Furness, MS
Mello, NK
Rice, KC
Negus, SS
Citation: Mr. Brandt et al., Antinociceptive effects of delta-opioid agonists in rhesus monkeys: Effects on chemically induced thermal hypersensitivity, J PHARM EXP, 296(3), 2001, pp. 939-946
Authors:
McLamore, S
Ullrich, T
Rothman, RB
Xu, H
Dersch, C
Coop, A
Davis, P
Porreca, F
Jacobson, AE
Rice, KC
Citation: S. Mclamore et al., Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5 alpha-epoxy-3,14-dihydroxy-6,7 : 2 ',3 '-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy, J MED CHEM, 44(9), 2001, pp. 1471-1474
Authors:
Zhang, Y
Joseph, DB
Bowen, WD
Flippen-Anderson, JL
Dersch, CM
Rothman, RB
Jacobson, AE
Rice, KC
Citation: Y. Zhang et al., Synthesis and biological evaluation of tropane-like 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl) piperazine (GBR 12909) analogues, J MED CHEM, 44(23), 2001, pp. 3937-3945
Authors:
Yu, H
Rothman, RB
Dersch, CM
Partilla, JS
Rice, KC
Citation: H. Yu et al., Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters, BIO MED CH, 8(12), 2000, pp. 2689-2692
Authors:
Ullrich, T
Rice, KC
Citation: T. Ullrich et Kc. Rice, A practical synthesis of the serotonin 5-HT2A receptor antagonist MDL 100907, its enantiomer and their 3-phenolic derivatives as precursors for [C-11]labeled PET ligands, BIO MED CH, 8(10), 2000, pp. 2427-2432
Authors:
Hsin, LW
Webster, EL
Chrousos, GP
Gold, PW
Eckelman, WC
Contoreggi, C
Rice, KC
Citation: Lw. Hsin et al., Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor, BIOORG MED, 10(8), 2000, pp. 707-710
Authors:
Coop, A
Jacobson, AE
Aceto, MD
Harris, LS
Traynor, JR
Woods, JH
Rice, KC
Citation: A. Coop et al., N-cyclohexylethyl-N-noroxymorphindole: A mu-opioid preferring analogue of naltrindole, BIOORG MED, 10(21), 2000, pp. 2449-2451
Authors:
Kirby, LG
Rice, KC
Valentino, RJ
Citation: Lg. Kirby et al., Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus, NEUROPSYCH, 22(2), 2000, pp. 148-162
Authors:
Baumann, MH
Ayestas, MA
Dersch, CM
Brockington, A
Rice, KC
Rothman, RB
Citation: Mh. Baumann et al., Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications, SYNAPSE, 36(2), 2000, pp. 102-113
Authors:
Rothman, RB
Partilla, JS
Baumann, MH
Dersch, CM
Carroll, FI
Rice, KC
Citation: Rb. Rothman et al., Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: A pharmacological strategyfor treating stimulant abuse, SYNAPSE, 35(3), 2000, pp. 222-227
Authors:
Hsin, LW
Webster, EL
Chrousos, GP
Gold, PW
Eckelman, WC
Contoreggi, C
Rice, KC
Citation: Lw. Hsin et al., Synthesis of [H-3] (4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: A potent radioligand for corticotropin-releasing hormone type 1 receptor, J LABEL C R, 43(9), 2000, pp. 899-908
Authors:
Partilla, JS
Dersch, CM
Yu, H
Rice, KC
Rothman, RB
Citation: Js. Partilla et al., Neurochemical neutralization of amphetamine-type stimulants in rat brain by the indatraline analog (-)-HY038, BRAIN RES B, 53(6), 2000, pp. 821-826
Authors:
Hope, PJ
Turnbull, H
Farr, S
Morley, JE
Rice, KC
Chrousos, GP
Torpy, DJ
Wittert, GA
Citation: Pj. Hope et al., Peripheral administration of CRF and urocortin: effects on food intake andthe HPA axis in the marsupial Sminthopsis crassicaudata, PEPTIDES, 21(5), 2000, pp. 669-677